Controlled release compositions of tizanidine
US8524749B2 · kind B2 · utility
0Cited by
45References
12Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jan 16, 2008 |
| Grant date | Sep 3, 2013 |
| Priority date | — |
| Expiry date | Feb 10, 2030 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P21/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to a novel controlled release formulations of tizanidine. The invention also provides methods of using novel controlled release formulations of tizanidine to treat a patient.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.